Point72 Asset Management L.P. 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:53 pm Sale |
2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management L.P. | 2,709,292 3.000% |
-1,723,310 (-38.88%) |
Filing |
| 2024-02-23 4:15 pm Purchase |
2024-02-22 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management L.P. | 4,432,602 5.000% |
435,057 (+10.88%) |
Filing |
| 2024-02-14 06:30 am Sale |
2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management L.P. | 3,997,545 4.500% |
-87,999 (-2.15%) |
Filing |
| 2023-07-20 4:15 pm Purchase |
2023-07-18 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management L.P. | 4,085,544 5.100% |
4,085,544 (New Position) |
Filing |